Literature DB >> 1225826

Incidence of congenital heart disease in Hungary.

M Mészáros, A Nagy, A Czeizel.   

Abstract

A survey was planned for establishing the point prevalence at birth of congenital heart disease and for assessing at the same time the efficacy of a screening for such anomalies. This model included: (1) exact determination of the population under survey; (2) approximately complete ascertainment of all persons in the population studied; (3) identical principles of cardiologic screening; (4) application of modern cardiologic diagnostic methods, and (5) a sample of over 2,000 persons. 23 cases of congenital heart diseases were found among 2,259 children born 1963 in a defined Hungarian territory. This means a point prevalence of 10.2+/-2.1% live births. (An additional 6 doubtful cases were not taken into account.) From the 12 cases diagnosed in vivo, 10 were detected by the screening.

Entities:  

Mesh:

Year:  1975        PMID: 1225826     DOI: 10.1159/000152769

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  4 in total

1.  Maternal hypertension with nifedipine treatment associated with a higher risk for right-sided obstructive defects of the heart: a population-based case-control study.

Authors:  Melinda Csáky-Szunyogh; Attila Vereczkey; Balázs Gerencsér; Andrew E Czeizel
Journal:  Heart Asia       Date:  2014-01-23

2.  Study of children of parents operated on for congenital cardiovascular malformations.

Authors:  A Czeizel; A Pornoi; E Péterffy; E Tarcal
Journal:  Br Heart J       Date:  1982-03

3.  Two family studies of children with ventricular septal defect.

Authors:  A Czeizel; M Mészáros
Journal:  Eur J Pediatr       Date:  1981-03       Impact factor: 3.183

4.  Risk factors in the origin of congenital left-ventricular outflow-tract obstruction defects of the heart: a population-based case-control study.

Authors:  Melinda Csáky-Szunyogh; Attila Vereczkey; Zsolt Kósa; Balázs Gerencsér; Andrew E Czeizel
Journal:  Pediatr Cardiol       Date:  2013-07-11       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.